Pyng Medical Corp.

Pyng Medical Corp.

November 14, 2007 14:27 ET

Pyng Medical Featured on BNN Power Breakfast

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 14, 2007) - Pyng Medical Corp. (TSX VENTURE:PYT) was featured on the Business News Network "Power Breakfast" show with host Linda Sims on 7 November 2007 (

The stock market responded positively with the share price climbing to 85 cents, up from the opening price of 55 cents. 485,930 shares were traded, closing at 73 cents, a 33% increase over the prior day close.

"When we have the opportunity to tell our story to the public the market responds favorably," said David Christie, President and Chief Executive Officer. "We have a lot of exciting things happening with our business. Results are good, our growth trajectory continues and we will keep putting the word out. We believe that Pyng's stock is undervalued and now is a great time to buy."

About Pyng Medical Corp.

Pyng Medical Corporation has been on the leading edge of life saving medical technology since the launch of its proprietary, award-winning FAST1™ Intraosseous Infusion System in 1997. Pyng was selected in the "2007 TSX Venture 50" Top 10 companies in Life Sciences, based on solid financial metrics for the year ending December 31, 2006. With expanding markets in North America, Europe and Asia, the FAST1™ has been adopted worldwide for use on the street, in the hospital, and in the battlefield.

Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • Pyng Medical Corp.
    David Christie
    (604) 303-7964